The Cooper Companies, Inc. (NASDAQ:COO) Given Average Rating of “Moderate Buy” by Brokerages

The Cooper Companies, Inc. (NASDAQ:COO) has been assigned a consensus rating of “Moderate Buy” from the ten analysts that are currently covering the company, MarketBeat.com reports. Two analysts have rated the stock with a hold recommendation and eight have issued a buy recommendation on the company. The average 12 month price target among analysts that have issued a report on the stock in the last year is $117.22.

COO has been the subject of several research reports. Morgan Stanley reduced their price objective on Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating for the company in a research note on Friday, December 6th. Needham & Company LLC reissued a “hold” rating on shares of Cooper Companies in a research note on Friday, December 6th. StockNews.com lowered Cooper Companies from a “buy” rating to a “hold” rating in a research note on Wednesday, December 11th. Citigroup reduced their price objective on Cooper Companies from $116.00 to $115.00 and set a “buy” rating for the company in a research note on Friday, December 6th. Finally, Wells Fargo & Company raised their price objective on Cooper Companies from $115.00 to $118.00 and gave the stock an “overweight” rating in a research note on Friday, December 6th.

Institutional Trading of Cooper Companies

A number of hedge funds have recently modified their holdings of the business. Universal Beteiligungs und Servicegesellschaft mbH purchased a new stake in shares of Cooper Companies in the fourth quarter valued at $17,392,000. Jefferies Financial Group Inc. raised its holdings in shares of Cooper Companies by 138.9% during the fourth quarter. Jefferies Financial Group Inc. now owns 48,514 shares of the medical device company’s stock worth $4,460,000 after acquiring an additional 28,204 shares in the last quarter. Mackenzie Financial Corp raised its holdings in shares of Cooper Companies by 12.4% during the fourth quarter. Mackenzie Financial Corp now owns 19,910 shares of the medical device company’s stock worth $1,830,000 after acquiring an additional 2,193 shares in the last quarter. Forum Financial Management LP raised its holdings in shares of Cooper Companies by 107.3% during the fourth quarter. Forum Financial Management LP now owns 3,840 shares of the medical device company’s stock worth $353,000 after acquiring an additional 1,988 shares in the last quarter. Finally, Castlekeep Investment Advisors LLC purchased a new stake in shares of Cooper Companies during the fourth quarter worth $685,000. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Cooper Companies Stock Performance

Shares of NASDAQ COO opened at $90.98 on Friday. The stock has a fifty day moving average price of $92.56 and a two-hundred day moving average price of $99.51. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91. The firm has a market cap of $18.16 billion, a P/E ratio of 46.66, a PEG ratio of 2.25 and a beta of 1.02. Cooper Companies has a 1 year low of $84.76 and a 1 year high of $112.38.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.92. The firm had revenue of $964.70 million during the quarter, compared to analyst estimates of $981.25 million. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. Research analysts forecast that Cooper Companies will post 3.98 EPS for the current fiscal year.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.